Urology
Latest news
133 articles · 20 / page
Vaginal Lasers in Stress Urinary Incontinence: Evaluating Efficacy and Safety through an Abridged Cochrane Review
This article reviews current evidence from a Cochrane systematic review on vaginal laser therapy for stress urinary incontinence in women, highlighting uncertain efficacy and safety profiles compared to sham and other treatments.
Biparametric MRI Matches Multiparametric MRI for Prostate Cancer Diagnosis: Insights from the PRIME Trial
The PRIME trial demonstrates that biparametric MRI, omitting contrast enhancement, is noninferior to multiparametric MRI in detecting clinically significant prostate cancer, offering a faster, cost-effective alternative potentially transfor
Microsurgical Advances and Clinical Outcomes in Penile Replantation: Overcoming Complex Reconstructive Challenges
This article reviews microsurgical techniques and patient outcomes in penile replantation, highlighting complications, innovative management strategies, and the critical need for standardized protocols to improve functional and aesthetic re
Underutilization of PARP Inhibitors in Metastatic Prostate Cancer With BRCA1/2 Alterations: Insights from a US Real-World Cohort
Despite proven survival benefit, nearly half of patients with metastatic castration-resistant prostate cancer harboring BRCA1/2 alterations did not receive PARP inhibitors in a US real-world study, highlighting critical gaps in treatment ac
PSMA PET-Guided Intensification of Salvage Radiotherapy Enhances Outcomes Post-Radical Prostatectomy: Insights from a Phase 2 RCT
A phase 2 randomized trial demonstrates that PSMA-PET-guided intensification of salvage radiotherapy after radical prostatectomy significantly improves failure-free survival without added toxicity.
Advancing Treatment in Oligometastatic Castration-Resistant Prostate Cancer: The GROUQ-PCS 9 Trial on SBRT Plus Standard Systemic Therapy
The GROUQ-PCS 9 trial demonstrates that adding stereotactic body radiotherapy to standard androgen deprivation therapy and enzalutamide significantly prolongs radiographic progression-free survival in oligometastatic castration-resistant pr
How Often Should Men Have Sex? Harvard Study Links 21 Times a Month to Lower Prostate Cancer Risk
A large Harvard study finds that frequent ejaculation—about 21 times a month—is associated with a significantly reduced risk of prostate cancer among men, offering new insights into modifiable factors for prevention.
Enhancing Outcomes in Metastatic Castration-Resistant Prostate Cancer: The EORTC 1333/PEACE-3 Trial of Enzalutamide Combined with Radium-223
The PEACE-3 trial demonstrates that adding radium-223 to enzalutamide significantly improves radiological progression-free survival and suggests an overall survival benefit in metastatic castration-resistant prostate cancer with bone metast
Rizedisben Enhances Nerve Visualization in Minimally Invasive Prostate Surgery: Insights from a Phase 1 Dose-Escalation Trial
This phase 1 trial identifies 3.0 mg/kg as the optimal safe and effective dose of rizedisben, a novel myelin-binding fluorophore, enhancing sustained intraoperative nerve fluorescence during robot-assisted laparoscopic radical prostatectomy
Unveiling the Hidden Risks of 5G Radiation: Impacts on Male Fertility
Recent animal studies suggest daily 5G phone radiation exposure may significantly impair sperm quality, raising concerns over modern lifestyle and reproductive health.
Behavioral Therapy Matches Drug Efficacy for Overactive Bladder in Parkinson’s Disease: Insights from a Randomized Noninferiority Trial
A 12-week randomized trial demonstrates that behavioral therapy is noninferior to solifenacin in treating overactive bladder symptoms in Parkinson disease, with fewer adverse effects, supporting behavioral therapy as a frontline treatment o
The Silent Decline: Understanding the Post-Pandemic Drop in Sexual Activity Among Americans
A recent study highlights a historic decline in sexual activity in the U.S., driven by societal, psychological, and lifestyle factors, affecting all ages and calling for renewed attention to sexual health.
AI Foundation Model Revolutionizes Non-Invasive Diagnosis and Grading of Prostate Cancer
A multidisciplinary Chinese team has developed an AI-driven MRI-pathology foundation model that enables accurate, non-invasive diagnosis and grading of prostate cancer, significantly improving clinical decision-making and reducing unnecessa
Frequent Ejaculation and Prostate Cancer Risk: Insights from a Landmark Harvard Study
A large Harvard study shows men ejaculating 21+ times monthly have a significantly reduced overall risk of prostate cancer, especially low-risk forms, across different life stages.
Is Microplastic Pollution Silently Eroding Male Vitality and Fertility?
Over 45 years, male physiological function has declined by 62%, possibly due to microplastic pollution. This article explores the science behind microplastics’ impact on male health and emerging approaches for prevention and treatment.
Case Report: Unilateral Renal Agenesis Presenting as Recurrent Urinary Tract Infections in a 25-Year-Old Woman
A 25-year-old woman with recurrent urinary tract infections was diagnosed with unilateral renal agenesis, highlighting the importance of imaging in persistent urinary symptoms.
Pumpkin Seeds and Male Erectile Dysfunction: Unveiling Nature’s Potential to Restore Male Health
Recent research reveals that dietary supplementation with pumpkin seeds significantly improves male erectile function by modulating key biological regulators, providing a natural and safe alternative to traditional ED medications.
Statin Use and Survival Benefits in Advanced Prostate Cancer Patients Receiving Apalutamide: Insights from the TITAN and SPARTAN Trials
Statin exposure is linked to improved overall survival in prostate cancer patients treated with apalutamide but raises the risk of severe cardiac adverse events due to underlying cardiovascular conditions.
Iterum Therapeutics Launches New Oral Antibiotic for Urinary Tract Infections
Iterum Therapeutics has launched Orlynvah, the first oral penem antibiotic approved in the US for uncomplicated urinary tract infections, addressing growing antibiotic resistance.
Clinical Applications of Serenoa repens in Benign Prostatic Hyperplasia and Related Urological Conditions: An Evidence-Based Review
This review synthesizes clinical evidence on Serenoa repens efficacy and safety in benign prostatic hyperplasia and associated lower urinary tract symptoms, highlighting mixed findings and mechanistic insights from randomized trials and met
Browse by specialty
Open language-specific specialty feeds and department pages.